FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

Morra R, Lebray P, Ingiliz P, Ngo Y, Munteanu M …

MeSH — NLM indexing Aspartate Aminotransferases / blood Biomarkers / blood Hepatitis C, Chronic / complications Humans Liver Cirrhosis / blood Liver Cirrhosis / diagnosis Liver Cirrhosis / virology Platelet Count Prognosis

Autres publications de Morra R

Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.

Aliment Pharmacol Ther · 2007

FibroMAX: towards a new universal biomarker of liver disease?

Expert Rev Mol Diagn · 2007

Sur le même sujet

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Biomedicines · 2025

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

World J Hepatol · 2025

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Cardiovasc Diabetol · 2025

Noninvasive Assessment of Liver Fibrosis.

N Engl J Med · 2025

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Diabetes Care · 2025

Toward non-invasive assessment strategies in autoimmune hepatitis.

World J Hepatol · 2025